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Abstract
Bovine neonatal pancytopenia (BNP; previously known as idiopathic haemorrhagic diathesis and commonly known as
bleeding calf syndrome) is a novel haemorrhagic disease of young calves which has emerged in a number of European
countries during recent years. Data were retrospectively collected during June to November 2010 for 56 case calves
diagnosed with BNP between 17 March and 7 June of the same year. These were compared with 58 control calves randomly
recruited from herds with no history of BNP. Multivariable logistic regression analysis showed that increased odds of a calf
being a BNP case were associated with its dam having received PregSureH BVD (Pfizer Animal Health) vaccination prior to
the birth of the calf (odds ratio (OR) 40.78, p,0.001) and its herd of origin being located in Scotland (OR 9.71, p = 0.006).
Decreased odds of a calf being a BNP case were associated with the calf having been kept outside (OR 0.11, p = 0.006). The
longer that a cattle herd had been established on the farm was also associated with decreased odds of a calf in that herd
being a BNP case (OR 0.97, p = 0.011).
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Introduction
Bovine neonatal pancytopenia (BNP) was previously known as
idiopathic haemorrhagic diathesis and is commonly known as
bleeding calf syndrome. It is a novel haemorrhagic disease of
young calves which has emerged in a number of European
countries during recent years. This disease has been reported
across Great Britain (GB) [1,2], in the Republic of Ireland [3] and
in a number of countries on mainland Europe [4].
BNP typically affects calves younger than one month old,
independent of breed or sex. Clinical signs in affected calves may
include cutaneous haemorrhage, petechiation of mucosae, melae-
na and pyrexia, although some affected calves are found dead
without clinical signs being observed. The typical haematological
finding is thrombocytopenia, which may be accompanied by
neutropenia, lymphopenia and non-regenerative anaemia. Histo-
pathology of the bone marrow of affected calves reveals trilineage
hypoplasia involving simultaneous, extensive, pronounced reduc-
tion in all three main haematopoietic cell series. The haemato-
logical and pathological findings suggest that destruction of bone
marrow progenitor cells leads to hypoplastic pancytopenia and
consequently haemorrhage due to thrombocytopenia [5]. On
affected farms, the incidence of clinical cases is generally low but
the case fatality rate is very high and can become important at the
individual farm level, with losses of up to 5% of calves in a herd
being reported [4,5].
Investigations into the aetiology of BNP are on-going in a
number of countries. A German study reported the detection of
circovirus DNA in 5 out of 25 cases of BNP but also in 1 out of 8
unaffected control calves [6]; other studies have found no evidence
to suggest a viral aetiology for BNP [4,7]. Limited studies have
been unable to demonstrate a simple mode of inheritance by
investigation of a mutation in factor XI [8] or by investigation of
major histocompatibility complex allelic frequencies [9]. It has
been observed that BNP can be induced in some calves by
ingestion of colostrum harvested from cows which have previously
given birth to calves which developed BNP [10], and it has been
suggested that alloantibodies from colostrum may play a crucial
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role in the pathogenesis of BNP [11]. Sera of PregSureH BVD
(Pfizer Animal Health) vaccinated BNP dams have been shown to
contain alloreactive leukocyte-binding antibodies and these
alloantibodies cross-react with the bovine kidney cell line used
for PregSureH BVD production [12]. There is also evidence that
some PregSureH BVD induced alloantibodies recognise cattle
major histocompatibility complex class I antigen [13]. Nonethe-
less, the exact aetiology and pathophysiology of BNP remains to be
fully elucidated.
In order to investigate common factors in calves developing
BNP, a case-series study of 75 clinical cases of BNP was conducted
by the Veterinary Laboratories Agency (VLA) and Scottish
Agricultural College (SAC) during 2009 [14]. This study also
provided material to investigate the potential involvement of
infectious agents or other causes of bone marrow suppression and,
through a defined necropsy protocol, to provide a definitive
histopathological description of the disease [15]. Factors which
occurred in more than 60% of case calves in this study included
vaccination of the calf’s dam with at least one vaccine during the
12 month period prior to the birth of the calf of interest or the 4
week period thereafter, ingestion of maternal colostrum, addition
of cattle to the herd during the previous 12 months and the
presence of sheep on the farm. Case-series studies can provide a
useful insight into factors that may be associated with a novel
disease, but only provide weak evidence due to the absence of a set
of control animals for comparison. These preliminary findings
were therefore used to inform the design of the case-control study
reported here, which aimed to investigate the association between
putative risk factors and clinical BNP in calves in GB.
Methods
A case-control study was designed to estimate the strength of
association between putative risk factors and the occurrence of
clinical BNP in calves in GB. Potential risk factors were selected
based on information from a previous case-series study [14] and
from the available literature and expert opinion at that time. The
study was carried out by the VLA and SAC, both delivery agents
for Government farm animal disease scanning surveillance in GB.
As part of this function, the VLA and SAC provide a laboratory-
based farm animal diagnostic service, including necropsies, to
private veterinary surgeons (PVSs).
Sample Criteria
The sampling frame for this study was the British calf
population; the unit of study was defined as the individual calf.
However, since potential risk factors were both animal-level and
herd-level, recruitment for this study was restricted to a single calf
per farm. In order to facilitate accurate data collection, calves were
ineligible for the study if they had moved from one herd to
another, and thus were no longer in their birth herd.
Case Definition
A case was defined as a calf 28-days-old or younger, with
unexplained haemorrhages detected at necropsy, and trilineage
hypoplasia of bone marrow confirmed by histopathology. Triline-
age hypoplasia was defined as concurrent depletion of erythroid
and myeloid cells and megakaryocytes from bone marrow
resulting in less than 25% cellularity [15]. A notional date of
enrolment into the study, for each case, was defined as the date on
which the necropsy was carried out.
Control definition. For each case calf, a control calf,
matched by purpose of herd of origin i.e. beef cow herd or dairy
herd, was selected at random from the British calf population.
Thus the cases and controls were frequency matched to include
the same proportions of calves from beef cow and dairy herds. A
control was defined as a calf that had never shown any evidence of
clinical disease.
It was a requirement that control calves were aged between 28
and 56-days-old on the notional date of enrolment of the case calf.
This age range ensured that control calves had passed through the
‘at risk’ period for development of BNP (7 to 28-days-old), and
allowed a margin for the possibility of late onset cases. Linking
control calf age with the notional date of enrolment for the case
calf ensured a similar representation of cases and controls born in
each month throughout the study period; thus control calves
represented the ‘at risk’ population during the same period that
the case calves were enrolled. Furthermore, it minimised potential
differences in recall bias between cases and controls.
Control calves were recruited from herds with at least 100 adult
($2 years old) female cattle present. It was a requirement that, at
the time of enrolment and through to the end of the study period,
herds providing control calves had no history of a diagnosis of
BNP and no history of calves:
N ,29-days-old presenting with apparent spontaneous haemor-
rhage from the skin or with excessive or prolonged
haemorrhage from wound sites such as ear tag wounds and
injection sites (from 1 January 2007);
N ,29-days-old presenting with melaena (from 1 January 2009);
N 7 to 30-days-old found dead in the absence of premonitory
clinical signs (from 1 September 2009).
Exclusion criteria. Exclusion criteria were implemented to
further ensure that there were no unmonitored animals in a
‘control herd’, that could have shown signs of disease as described
above, and which would therefore have led to exclusion of a
selected calf as a control. Calves were considered ineligible if they
originated from herds in which, from 1 January 2009 through to
the end of the study period, any healthy male calves in the herd
were humanely slaughtered before they reached 29-days-old or
any calves (male or female) were sold before they reached 29-days-
old. To ensure that case and control calves were recruited from the
same general population of calves, these criteria were also applied
to case calves.
Enrolment
Case selection. Case enrolment took place retrospectively
from June to November 2010. Case calves were identified through
voluntary submission of animals to VLA Regional Laboratories
and SAC Disease Surveillance Centres for necropsy. Such
submissions were encouraged by the offer of free necropsy
examination of suspect cases. The owners of all herds with case
calves diagnosed between 17 March and 7 June 2010 were
randomly ordered and contacted, initially by telephone, to seek
their consent to participate in the study. If multiple case calves had
been detected in a selected herd at the time of contact, then a
single case calf was selected at random. Once a calf had been
recruited from a herd, no further calves from that herd were
eligible for inclusion in the study.
Control selection. Control calves were selected from beef
cow and dairy herd population data, obtained using the Rapid
Analysis and Detection of Animal-related Risks (RADAR)
information management system [16]. RADAR accesses informa-
tion from the Cattle Tracing System, which records the
identification, death and movements of all cattle issued with
passports from 1998 onwards, and all movements of older cattle.
From this, a randomly ordered list of herds (excluding known ‘case
Bovine Neonatal Pancytopenia: A Case Control Study
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e34183
herds’) was produced. Herds on this list were contacted in
sequential order by a VLA staff member and assessed for
willingness to participate and eligibility. If a herd was not willing
to participate or was ineligible, the next herd on the list (of the
same herd purpose) was contacted. Once a potential ‘control herd’
was identified, the youngest calf in that herd, meeting the control
definition, was identified as the control calf.
Sample Size
A minimum sample size of 56 case and 56 control calves was
calculated using Win Episcope 2.0 [17] to provide 95% confidence
of detecting an odds ratio (OR) of 3 or more provided the
exposure rate amongst controls lay between 28 and 47% (designed
to encompass exposures to a range of potential risk factors in the
national herd). This calculation was predicated on univariable
analyses; risk factors which were found significant at the
univariable stage would be further investigated through multivar-
iable analyses.
Data Collection
Data collection took place during June to November 2010. VLA
and SAC Veterinary Investigation Officers (VIOs) conducted
personal interviews with the owners of case and control calves, or
with a suitable representative of the owner, using a standard
questionnaire (Information S1). The questionnaire captured
information on a number of herd-level and animal-level exposures,
and is summarised in Table 1.
In order to validate the reported dam vaccination histories, the
VIOs conducting the interviews scrutinised each farm’s Animal
Medicine Record Book, if this record was available at the time of
the interview. All farmers in GB are required by law to record the
administration of all medicines to food producing animals. Each
owner was also asked to authorise disclosure by their PVS of
vaccine sales records for the herd. For each herd with an
incomplete on-farm written or electronic record of the dam
vaccination history in question, the relevant vaccine sales records
were obtained from the herd’s PVS. There is evidence that BNP
results from a factor present in the colostrum of certain cows [10],
so reports of vaccination were only included in the dataset if the
vaccination had been administered to the dam before the birth of
the calf of interest.
Subsequent to the data collection interview, the owners of
control calves were telephoned fortnightly by VLA and SAC
VIOs. If any control became ineligible before the end of the study
period, that calf and herd were rejected and replaced with a new
eligible calf, from a new herd.
Analysis
All statistical analyses were carried out in Stata 10.0 (Statacorp,
College Station, TX). All variables were entered individually into a
univariable logistic regression model. However, since the cases and
controls were frequency matched on herd purpose, in each step
the variable ‘herd purpose’ (beef cow herd or dairy herd) was
included in the model, so that ORs calculated were adjusted for
the stratification in the data. Variables were selected for inclusion
in a multivariable model if p,0.1, in order to ensure that variables
of interest were not omitted.
Subsequently, all variables significant in univariable analyses
were entered into a multivariable logistic regression model and a
backwards stepwise logistic regression was carried out; the variable
with the highest p-value was removed and the model re-run. This
process was repeated until all variables remaining in the model
were significant (using a more stringent critical value of p,0.05).
The possibility of collinearity between predictor variables was
addressed initially by seeking correlations between the explanatory
variables and, following the model fitting, by stepwise removal of
variables to assess the effect on the remaining variable coefficients.
Furthermore, after model fitting, variance inflation factors (VIF)
[18] were calculated and examined. Model fit was examined using
Hosmer & Lemeshow’s goodness of fit test and a linktest [18].
These methods, in combination with likelihood ratio tests as
appropriate, were used to compare logistic regression models to
clustered, random effects (using herd purpose as a cluster/random
effect variable) and conditional logistic regression models (treating
cases and controls as individually matched) to ensure that the final
model was the most suitable for the data structure.
Table 1. Information collected in the study questionnaire.
Level Information
Herd details Location and cattle farming history.
Organic/standard/converting.
Size and composition.
Cattle movements onto the farm, since 2007.
Contact with cattle on other farms, since 2007.
Contact with sheep on this and other farms, since 2007.
Calf details Date of birth and sex.
Colostrum management.
Housing.
Dam details Date of birth and time on the farm.
Contact with cattle on other farms, while pregnant with the calf of interest.
Contact with sheep on this and other farms, whilst pregnant with the calf of interest.
Diet.
Vaccination history (including dates and batch numbers for all vaccines used) since the start of 2005.
Other Dam and sire breed.
doi:10.1371/journal.pone.0034183.t001
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Where appropriate, and if further information was available,
variables significant in the final model were subject to further
analyses, in order to better understand the nature of the
association between BNP and each risk factor.
Results
Descriptive Statistics
During the study period, 56 eligible case calves were identified
and enrolled into the study. A total of 312 potential ‘control herds’
were contacted; of these herds, 33% did not respond to any
contact, 31% declined and 18% were found to be ineligible.
Ineligible herds were mainly those selling calves less than 29-days-
old or humanely slaughtering healthy male calves less than 29-
days-old (17 farms) or herds that had calves with a clinical
presentation requiring exclusion (13 farms). This provided a total
of 58 eligible control calves. A Yates-corrected chi-squared test
was used to evaluate any differences in participation between
‘control herds’ in Scotland and ‘control herds’ in England and
Wales. A higher percentage of Scottish dairy herds (67%) declined
to participate in the study compared with English or Welsh dairy
herds (25%; p,0.05). A higher percentage of Scottish beef cow
herds (20%) were ineligible for the study compared with English or
Welsh beef cow herds (7%; p,0.05).
Data were collected for the 56 eligible case calves and the 58
eligible control calves. One control calf was rejected when BNP
was diagnosed in its herd during the study period, and a
replacement calf was recruited from another herd. During March,
April, May and June, 19, 55, 38 and 2 calves were enrolled into
the study, respectively. One control calf was 57-days-old on its
notional date of enrolment, but was retained in the study due to
time constraints on data collection.
Table 2 shows, by case/control status and herd purpose, the
number of herds recruited in England and Wales, and Scotland,
and the mean total herd sizes and number of calves. Mean dam
age was 6.2 years and 5.5 years for control and case calves
respectively, and there was no evidence of any significant
difference between them.
Of the 114 calves in the study, 111 received colostrum from
their dam. Of the three that did not receive colostrum from their
dam, one received pooled colostrum (case), one received pooled
colostrum and ‘other’ colostrum (case), and one received ‘other’
colostrum (control). One calf that received colostrum from its dam
also received commercial colostrum (control).
Final Model
The variables remaining in the model after stepwise logistic
regression are shown in Table 3. There were four missing values in
the ‘PregSureH BVD use’ variable and one missing value in the
‘years cattle herd established on farm’ variable. Therefore the
model is based on 109 data points, of which 54 were control and
55 were case calves. All VIF values were ,2 (mean: 1.35), thus
collinearity was not considered a problem [18]. Using Hosmer and
Lemeshow’s goodness of fit test [18], the model fit was satisfactory
(p = 0.247) and the linktest for specification error was not
significant (p = 0.674). No other type of model improved the fit
of the data.
The odds of a calf being a BNP case decreased if the calf had
been kept outside. Housing types were not mutually exclusive, as
animals could have been kept both inside and out, therefore the
variable ‘calf kept outside’ was explored in more detail using a
variable with three categories: calf kept outside only (n = 15); calf
housed indoors only (n = 39); calf kept both indoors and outside at
some stage (n = 55). In this instance, the variable remained
significant (X2 = 10.12, df = 2, p = 0.006) with the odds of disease
being reduced in calves kept outside only and also calves kept
indoors and outside, compared with those housed indoors only
(ORs of 0.06 and 0.13 respectively).
The odds of a calf being a BNP case decreased as the number of
years for which the cattle herd had been established on the farm
increased. Herds with case calves had been established for a mean
of 30.9 years (CI 24.9, 36.8) and herds with control calves had
been established for a mean of 40.4 years (CI 33.6, 47.2).
The odds of a calf being a BNP case increased if the herd was in
Scotland and also increased if PregSureH BVD had been
administered to the calf’s dam at any time from the start of
2005 through to the birth of the calf. The dams of 50 of the 55
cases had received PregSureH BVD, compared with 14 of the 54
dams of controls. In order to better understand the association
with BNP, the ‘PregSureH BVD use’ variable was examined in
more detail. A new variable with four categories was created: no
Bovine Viral Diarrhoea Virus (BVDV) vaccine; vaccinated with
PregSureH BVD; vaccinated with PregSureH BVD plus other
BVDV vaccine; vaccinated with other BVDV vaccine. This
variable was significant when it replaced overall PregSureH BVD
Table 2. Breakdown of the characteristics of the herds included in the study.
Number of herds Mean number of animals per herd
Group Herd type Scotland England & Wales Calves Total cattle
Case Beef cow 44 6 132.4 450.1
Dairy 0 6 94.8 398.8
Control Beef cow 24 25 133.0 407.9
Dairy 0 9 91.3 360.1
doi:10.1371/journal.pone.0034183.t002
Table 3. Final logistic regression model of the factors
significantly associated with a change in the odds of a calf
being a BNP case.
Variable OR p wald 95% CI
Years cattle herd established on the
farm
0.97 0.011 0.94, 0.99
Herd in Scotland (Yes, 67:No, 42) 9.71 0.006 1.92, 49.14
Calf kept outside (Yes, 70:No, 39) 0.11 0.006 0.02, 0.53
PregSureH BVD administered to dam
(Yes, 64:No, 45)
40.78 ,0.001 10.14, 163.91
doi:10.1371/journal.pone.0034183.t003
Bovine Neonatal Pancytopenia: A Case Control Study
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e34183
use in the model presented in Table 3 (X2 = 43.60, df = 3,
p,0.001); both the second and third categories, which included
PregSureH BVD use, were associated with an increase in the odds
of a calf being a BNP case (ORs of 39.9 and 33.4 respectively).
The original binary ‘PregSureH BVD use’ variable was retained in
the model as it was more parsimonious.
PregSureH BVD may have been used at any time from 2005,
when the vaccine was first marketed in the UK. In 2005, 2006,
2007, 2008, 2009 and 2010, a total of 1, 13, 30, 52, 53 and 32
dams respectively were vaccinated with PregSureH BVD. When
inserted separately into the final model, replacing overall
PregSureH BVD use, an increase in the odds of a calf being a
BNP case was significantly associated with PregSureH BVD use in
each of 2007, 2008, 2009 and 2010 (p,0.001) and showed a trend
in the same direction for 2006 (p = 0.076). Although there is likely
to have been some collinearity between these variables, there was
no evidence to suggest that PregSureH BVD use in any particular
year was more significant.
Time since last vaccination of the dam with PregSureH BVD,
relative to the birth date of the calf of interest (included as a
continuous explanatory variable), was not significantly associated
with the likelihood of a calf developing BNP, either replacing
overall PregSureH BVD use in the final model, or in a bivariable
model stratified by herd purpose. An explanatory variable
comprising four categories was created: never used PregSureH
BVD; PregSureH BVD used before/on 31 December 2008;
PregSureH BVD used on/after 1January 2009; PregSureH BVD
used both before/on 31 December 2008 and on/after 1January
2009. PregSureH BVD use was associated with significantly higher
odds of a calf being a BNP case in all categories (X2 = 62.78,
df = 3, p,0.001), compared to never having used PregSureH
BVD; however, none of the ‘PregSureH BVD use’ categories
differed significantly from each other (ORs of 14.0, 7.8 and 62.8;
CI (1.3, 149.2), (1.4, 41.9) and (16.9, 234.3) respectively).
The number of doses of PregSureH BVD (total number of times
PregSureH BVD was administered to the dam) was examined; the
assumption was made that on each occasion a full dose was
administered. In a bivariable model using number of doses as a
categorical variable, stratified by herd purpose, all numbers of
doses of PregSureH BVD were significantly associated with an
increase in the odds of a calf being a BNP case (X2 = 57.20, df = 4,
p,0.001), but no number of doses differed significantly from any
other (Table 4). Dose was not considered to be a robust predictor
variable since we did not have a full lifetime vaccination history for
every dam.
The data were examined for any evidence of bias amongst cases
or controls in the reporting of PregSureH BVD use. The number of
years for which we had information on PregSureH BVD use for
each dam was examined as a proportion of all years for which
PregSureH BVD may have been used in each dam. This did not
differ significantly between the dams of cases and controls (mean
proportion: 0.97 and 0.91 respectively, p = 0.233).
Where dam vaccine records were not corroborated by an on-
farm written or electronic record, farmers’ PVSs were contacted to
obtain a copy of the relevant vaccine sales record. In only one case
did this affect the ‘PregSureH BVD use’ variable. PVS records
suggested that the owner of one case herd may have been sold an
alternative BVDV vaccine rather than PregSureH BVD, while the
initial record, based on owner recall, indicated PregSureH BVD
had been used. Sales records cannot confirm that the dam in
question was vaccinated with the alternative vaccine; however,
when the ‘PregSureH BVD use’ variable was adjusted to reflect this
change and tested in the final model, it did not affect any other
variables in the model, and PregSureH BVD use remained
significant (OR 33.71; CI 8.72, 130.24; p,0.001).
Discussion
In this study, data were collected for 56 case calves and 58
control calves. The study design required that only one calf was
recruited from any particular herd. Case and control notional
dates of enrolment were evenly distributed throughout the spring
in 2010 (from 17 March to 7 June). There was no statistically
significant difference in herd size between cases and controls, as
the slightly larger size of case herds observed could easily have
arisen by chance.
There is experimental evidence that a factor present in the
colostrum of certain cows is implicated in the pathogenesis of BNP
[10]. Therefore, it was important to ascertain the source of
colostrum for calves in this study. Almost all (96%) of the calves in
the study received colostrum only from their dam; consequently
colostrum-derived factors will be accurately represented by the
individual dam records collected.
As the sample size calculation was predicated on univariate
analysis then our power to detect risk factors that might have been
associated with an odds ratio below 3.0 is limited, particularly in
multivariate analysis. Nonetheless, a number of important risk
factors were observed. There was a strong association between
BNP status and a history of dam vaccination with the PregSureH
BVD vaccine, an inactivated BVDV type 1 vaccine. The odds of a
calf being a BNP case were at least 10 times higher (lower 95% CI
boundary) if its dam had been vaccinated with PregSureH BVD at
any time prior to the calf’s birth. In every year except 2005,
PregSureH BVD administration showed evidence of an association
with BNP status, and there was no evidence that the strength of
this association was notably different in any particular year,
although there is some loss of power due to the reduced sample
size in some years. There was no discernible effect of number of
doses. There was no association between time since last
vaccination with PregSureH BVD and BNP status; however, again
there is a loss of power since relatively few of the dams of control
calves (14 animals) had received PregSureH BVD. When time
since last vaccination was examined as a categorical variable, no
significant difference was observed between dams vaccinated in or
after 2009 and dams vaccinated before 2009. An effect of number
of occasions on which PregSureH BVD was administered may
have been difficult to identify since a full lifetime PregSureH BVD
vaccination history was not available for every dam; however,
there was no apparent difference in the completeness of these
records between cases and controls.
A potential link between PregSureH BVD and BNP has been
suggested [10,12,13]; the vaccine was withdrawn from the
Table 4. Breakdown of numbers of PregSureH BVD doses and
their association with the likelihood of a calf being a BNP case.
Number of:
No. of PregSureH BVD doses Cases Controls OR 95% CI
0 5 40 1.0 n/a
1 4 1 45.3 3.7, 561.3
2 7 5 12.0 2.7, 53.8
3 16 3 47.1 9.7, 228.7
4+ 24 5 38.1 9.9, 146.5
doi:10.1371/journal.pone.0034183.t004
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European market in 2010 [19]. Our study provides strong
epidemiological evidence of an association between PregSureH
BVD and BNP, but a case-control study cannot definitively
prove causation. An association between maternal vaccination
and induction of disease via colostral antibody has been
described previously in cattle, e.g. immune-mediated haemolytic
anaemia in calves following the use of vaccines against
anaplasmosis [20] and babesiosis [21,22]. In the case of BNP,
some cows produce alloantibodies which bind to calf peripheral
leukocytes [11,23] and such alloantibodies have been identified
in the sera of PregSureH BVD vaccinated BNP dams [12]. It is
plausible that these, or other induced alloantibodies, recognise a
target present on neonatal haematopoietic stem cells, triggering
their destruction and the development of trilineage hypoplasia
in the bone marrow of calves, following ingestion of colostrum.
This hypothesis could explain the development of the disease
only in calves and not in the dam. Furthermore, alloantibodies
directed against foetal lymphocyte antigens have been previously
detected in sera of primiparous cattle [24] and the possibility
that such antibodies may be elevated by dysregulation of the
immunology of pregnancy following vaccination cannot be
discounted. Further work to define the target antigen on
neonatal haemopoietic stem cells is required and other factors to
consider in future studies are the antigen, cell line and adjuvant
employed in the vaccine preparation and the timing and
frequency of vaccination.
The overall incidence of clinical BNP appears to be low in the
context of the number of doses of PregSureH BVD sold across a
number of European countries during recent years. The overall
incidence for BNP at European Union level between 2004 and
2009 was estimated to be 0.016% based on a single dose of
PregSureH BVD [25]. Consequently, it is possible that other
factors play an important role in the aetiology of BNP and further
studies to investigate these are required. However, although
clinical BNP appears to be a low incidence disease, the occurrence
of unrecognised subclinical disease also merits consideration.
Better characterisation of the markers of disease in the preclinical
stages should allow this effect to be investigated in experimental
challenge systems and on case farms.
We have considered whether the association with PregSureH
BVD identified by our study could be spurious due to
confounding with the presence of active BVDV infection in
the herds of interest; actively infected herds being possibly more
likely to use BVDV vaccines. Although the BVDV infection
status of the herds recruited into this study was not explicitly
confirmed, a vaccine association was only identified with
PregSureH BVD, despite three different BVDV vaccines having
been used in GB during recent years. Furthermore, there is
supportive temporal evidence for an association with PregSureH
BVD; BNP was not identified in GB prior to the introduction of
PregSureH BVD, although the other two BVDV vaccines were
available. No evidence has been reported that the pathogenesis
of BNP is associated with BVDV or other pestivirus (including
Border disease virus) infection of affected calves despite having
been extensively and explicitly sought [4,7]. Virological inves-
tigations carried out by the VLA, SAC and Moredun Research
Institute, involving screening 266 calves with histopathologically-
confirmed trilineage hypoplasia of bone marrow, by real-time
polymerase chain reaction, during 2009 and 2010, detected
BVDV in only one of these calves (unpublished data). As
BVDV infection is widespread in British cattle herds, it is to be
expected that the virus would be found on occasions in tissues
from calves that have died from causes not associated with
BVDV infection. Finally, although BVDV-induced thrombocy-
topenia and associated haemorrhage have been reported in
young calves [26], the pathogenesis of BVDV-induced throm-
bocytopenia is different to the pathogenesis of BNP. The
characteristic bone marrow pathology underlying BNP is
trilineage hypoplasia, consistent with an injury to pluripotential
haematopoietic stem cells. The depletion of megakaryocytes
leads to marked reduction in circulating thrombocytes and
hence the haemorrhagic diathesis observed in calves with BNP.
The lesion in calves affected with BNP is therefore distinctly
different from the selective targeting of megakaryocytes and
platelets that is a feature of pestivirus-induced thrombocytopenia
in both BVD and classical swine fever [27].
There was an association with herd location; Scottish herds
were 10 times more likely to contain a BNP calf than herds in
England and Wales. Total calf births in Scotland in the spring of
2009 amounted to 276,352, compared to 571,219 in England and
124,430 in Wales. Although Scotland had more calves born per
herd during the spring period (23 in Scotland, 12 in England and
10 in Wales), resulting in more calves per herd in the at-risk age
group for BNP during this period, in absolute terms there were still
more calves born in England and Wales during that time. Possible
explanations for the association with herd nationality include
greater awareness of BNP and its various clinical presentations
amongst Scottish cattle farmers and greater motivation of Scottish
cattle farmers to submit possible cases for investigation. It is also
notable that compared with English and Welsh farmers, a higher
percentage of the Scottish farmers who were contacted to request
provision of a control calf, declined to participate. This could have
biased control recruitment towards in English and Welsh herds. It
is also possible that another, unknown, causal factor is more
prevalent in Scotland.
The length of time for which the cattle herd had been
established on the farm was also associated with a change in the
odds of a calf being a BNP case. The likelihood of disease
decreased by 3% with every additional year that the cattle herd
had been present on the farm. Whilst it is possible to speculate on a
range of plausible explanations, analysis of the study data did not
offer any further insights and it is possible, especially in a small
study that such an association has arisen purely by chance.
Calves kept outside at any point during their life were less
likely to be BNP cases; calves that had been kept outside had
0.11 times the likelihood of being a case, compared with calves
housed indoors only. It was thought that this could have been
an artefact, since control calves had more opportunity to
experience a variety of ‘housing’ types. However, calves that
had been indoors and outside, and those that had been outside
only, had a reduced chance of being a case compared with
those housed indoors only, suggesting that a reduced risk of
disease was associated with being kept outside. Calves outside
may be less well monitored than calves indoors, resulting in a
greater likelihood of BNP cases being missed due to lack of
visibility or misidentification.
Conclusions
This case-control study has shown a strong association between
BNP and administration of PregSureH BVD to the dams of
affected calves. This association is not proof of causation and
further studies are required to elucidate the pathogenesis of the
development of the haematopoietic abnormalities underlying
BNP. Our power to detect any risk factors that might be more
weakly associated with BNP is limited by the sample size and it is
possible that presently unidentified factors are involved in the
development of BNP in individual animals.
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